FAST is excited to announce two new fellows: Dr. Xiaona Lu at Yale University and Dr. Xin Yang at Brown University. Fellowships such as these are important not only in supporting fundamental research that align with our Roadmap to a Cure, but also in providing opportunities to help build the next generation of scientific leaders to support and expand AS research.
Dr. Lu is a postdoctoral fellow mentored by Dr. Yong-Hui Jiang, and her work will focus on reactivating the paternal UBE3A gene, which falls under Pillar 2. Her career focuses on research that aims to improve the quality of life of individuals with genetic disorders, including Angelman syndrome. Her current training in Dr. Jiang's lab at Yale Genetics provides her the opportunity to explore and develop therapeutic strategies for individuals with Angelman syndrome.
Dr. Yang is a postdoctoral fellow mentored by Dr. Alvin Huang, and his work will focus on oligodendroglial dysfunction in AS, which falls under Pillar 3. Dr. Yang joined Dr. Huang’s laboratory at Brown University for a shared vision of innovation in research. Leveraging the induced pluripotent stem cell technique and traditional mouse models, his current focus is to understand the role of UBE3A in oligodendroglial physiology and pathophysiology, which could potentially accelerate the translation of novel therapeutic candidates for Angelman syndrome.
Learn more about these fellowships:
|